Tien Liang BioTech Co., Ltd. (TPEX:4127)
Taiwan
· Delayed Price · Currency is TWD 36.75
+0.10 (0.27%)
Jun 20, 2025, 12:31 PM CST
Tien Liang BioTech Revenue
Tien Liang BioTech had revenue of 116.60M TWD in the quarter ending March 31, 2025, a decrease of -1.08%. This brings the company's revenue in the last twelve months to 383.94M, down -15.20% year-over-year. In the year 2024, Tien Liang BioTech had annual revenue of 385.21M, down -16.26%.
Revenue (ttm)
383.94M
Revenue Growth
-15.20%
P/S Ratio
4.37
Revenue / Employee
5.05M
Employees
61
Market Cap
1.68B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 385.21M | -74.79M | -16.26% |
| Dec 31, 2023 | 459.99M | -68.53M | -12.97% |
| Dec 31, 2022 | 528.52M | -42.79M | -7.49% |
| Dec 31, 2021 | 571.32M | 140.23M | 32.53% |
| Dec 31, 2020 | 431.08M | -4.78M | -1.10% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Caliway Biopharmaceuticals | 40.47M |
| PharmaEssentia | 11.34B |
| Bora Pharmaceuticals Co., LTD. | 20.87B |
| Lotus Pharmaceutical | 19.12B |
| Oneness Biotech | 117.33M |
| Polaris Group | 87.67M |
| Center Laboratories | 1.63B |
| Lumosa Therapeutics | 43.59M |